Holen Sie sich die Stockscreener-App
11.22
0.97%
-0.12
Schlusskurs vom Vortag:
$11.34
Offen:
$11.4
24-Stunden-Volumen:
71,975
Relative Volume:
0.24
Marktkapitalisierung:
$412.47M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-12.47%
1M Leistung:
-11.16%
6M Leistung:
-31.19%
1J Leistung:
-57.20%
1-Tages-Spanne:
$11.16
$11.51
1-Wochen-Bereich:
$11.10
$12.82
52-Wochen-Spanne:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
11.25 | 415.77M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.48 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.58 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
360.81 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.03 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.30 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
How CeriBell Inc. stock benefits from tech adoption2025 Pullback Review & Stock Portfolio Risk Management - newser.com
CeriBell Inc. stock trend outlook and recovery pathPortfolio Risk Report & AI Driven Price Predictions - newser.com
Will CeriBell Inc. stock outperform international peersInsider Buying & Long-Term Capital Growth Strategies - newser.com
Will CeriBell Inc. stock maintain dividend yieldJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com
Will CeriBell Inc. stock outperform tech sector in 2025Profit Target & Low Risk Entry Point Guides - newser.com
Using economic indicators to assess CeriBell Inc. potentialWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Comparing CeriBell Inc. in custom built stock radarsWeekly Investment Recap & Fast Moving Market Watchlists - newser.com
Will CeriBell Inc. stock benefit from automationWeekly Volume Report & High Yield Equity Trading Tips - newser.com
Is CeriBell Inc. stock ready for a breakoutWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Can momentum traders help lift CeriBell Inc.2025 Dividend Review & Smart Allocation Stock Tips - newser.com
Can CeriBell Inc. stock outperform in 2025 bull marketEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
Ceribell Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
CeriBell, Inc. (CBLL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CBLL interactive stock chart | CeriBell, Inc. stock - Yahoo! Finance Singapore
Ceribell, Inc.: Strong Buy Rating Amid Market Potential and Clinical Advancements - TipRanks
Can CeriBell Inc. stock maintain operating margins2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
Ceribell’s Delirium Study: A New Frontier in EEG Technology - MSN
Does CeriBell (NASDAQ:CBLL) Have A Healthy Balance Sheet? - simplywall.st
CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Leading vs lagging indicators on CeriBell Inc. performancePortfolio Value Summary & Stock Portfolio Risk Management - newser.com
Is CeriBell Inc. stock a safe investment in uncertain marketsJuly 2025 Update & Real-Time Market Trend Scan - fcp.pa.gov.br
CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):